Synonyms: CXA-201 | CXA201 | YTR 830 | YTR 830H | Zerbaxa® (ceftolozane + tazobactam)
Compound class:
Synthetic organic
Comment: Tazobactam (CXA-201) is a β-lactamase inhibitor with antibacterial activity [1]. It is used alongside β-lactam-containing antibacterials to reduce their lactamase-induced degradation. Chemically tazobactam is a penicillin derivative, that binds as an irreversible inhibitor of β-lactamase.
|
|
No information available. |
Summary of Clinical Use ![]() |
Tazobactam is approved for clinical use in a number of countries, in combinations with β-lactamase sensitive antibacterials including ceftriaxone, piperacillin and cefepime. Zerbaxa®, which contains ceftolozane + tazobactam is authorised for use by the FDA and EMA. |